231
Views
0
CrossRef citations to date
0
Altmetric
Review Article

Mechanisms underlying the effects, and clinical applications, of oral microbiota in lung cancer: current challenges and prospects

, , , , , & show all
Received 06 Jan 2023, Accepted 08 Aug 2023, Published online: 11 Sep 2023

References

  • Abed J, Maalouf N, Parhi L, Chaushu S, Mandelboim O, Bachrach G. 2017. Tumor targeting by Fusobacterium nucleatum: a pilot study and future perspectives. Front Cell Infect Microbiol. 7:295. doi:10.3389/fcimb.2017.00295.
  • Abranches J, Zeng L, Kajfasz JK, Palmer SR, Chakraborty B, Wen ZT, Richards VP, Brady LJ, Lemos JA. 2018. Biology of oral Streptococci. Microbiol Spectr. 6(5):10. doi:10.1128/microbiolspec.GPP3-0042-2018.
  • Adler CJ, Malik R, Browne GV, Norris JM. 2016. Diet may influence the oral microbiome composition in cats. Microbiome. 4(1):23. doi:10.1186/s40168-016-0169-y.
  • Al Bataineh MT, Dash NR, Elkhazendar M, Alnusairat DMH, Darwish IMI, Al-Hajjaj MS, Hamid Q. 2020. Revealing oral microbiota composition and functionality associated with heavy cigarette smoking. J Transl Med. 18(1):421. doi:10.1186/s12967-020-02579-3.
  • Al-Ramahi N, Al-Najjar MAA, Jabaley A, Al-Qudah R, Basheti I. 2022. Variations in the respiratory microbiota amongst asthmatic and non-asthmatic subjects in Jordan. Saudi J Biol Sci. 29(10):103406. doi:10.1016/j.sjbs.2022.103406.
  • Aronson JK, Ferner RE. 2017. Biomarkers-a general review. Curr Protoc Pharmacol. 76:9.23.1–9.23.17. doi:10.1002/cpph.19.
  • Assi HI, Kamphorst AO, Moukalled NM, Ramalingam SS. 2018. Immune checkpoint inhibitors in advanced non-small cell lung cancer. Cancer. 124(2):248–261. doi:10.1002/cncr.31105.
  • Baldomero AK, Siddiqui M, Lo CY, Petersen A, Pragman AA, Connett JE, Kunisaki KM, Wendt CH. 2019. The relationship between oral health and COPD exacerbations. Int J Chron Obstruct Pulmon Dis. 14:881–892. doi:10.2147/COPD.S194991.
  • Banks JM, Brandini DA, Barbosa DB, Takamiya AS, Thakkar P, Zheng K, Naqvi AR. 2022. 5 - Leveraging microbicidal and immunosuppressive potential of herbal medicine in oral diseases. Herbal medicines. 91–137. doi:10.1016/B978-0-323-90572-5.00015-9
  • Beikler T, Bunte K, Chan Y, Weiher B, Selbach S, Peters U, Klocke A, Watt RM, Flemmig TF. 2021. Oral microbiota transplant in dogs with naturally occurring periodontitis. J Dent Res. 100(7):764–770. doi:10.1177/0022034521995423.
  • Bello S, Vengoechea JJ, Ponce-Alonso M, Figueredo AL, Mincholé E, Rezusta A, Gambó P, Pastor JM, Javier G, Del Campo R. Core microbiota in central lung cancer with streptococcal enrichment as a possible diagnostic marker. Arch Bronconeumol. 2021, 57(11):681–689. doi:10.1016/j.arbres.2020.05.034.
  • Bhavsar NV, Dave BD, Brahmbhatt NA, Parekh R. 2015. Periodontal status and oral health behavior in hospitalized patients with chronic obstructive pulmonary disease. J Nat Sci Biol Med. 6(Suppl 1):S93–S97. doi:10.4103/0976-9668.166097.
  • Bingula R, Filaire E, Molnar I, Delmas E, Berthon JY, Vasson MP, Bernalier-Donadille A, Filaire M. 2020. Characterisation of microbiota in saliva, bronchoalveolar lavage fluid, non-malignant, peritumoural and tumour tissue in non-small cell lung cancer patients: a cross-sectional clinical trial. Respir Res. 21(1):129. doi:10.1186/s12931-020-01392-2.
  • Bossé Y, Amos CI. 2018. A decade of GWAS results in lung cancer. Cancer Epidemiol Biomarkers Prev. 27(4):363–379. doi:10.1158/1055-9965.EPI-16-0794.
  • Brightling C, Greening N. 2019. Airway inflammation in COPD: progress to precision medicine. Eur Respir J. 54(2):1900651. doi:10.1183/13993003.00651-2019.
  • Cai Y, Zhao Y, Kang Y, Yang Y. 2022. Future prospect of oral microbiota influencing allergy/asthma development. Front Microbiol. 13:875664. doi:10.3389/fmicb.2022.875664.
  • Chen Y, Huang Y, Ding X, Yang Z, He L, Ning M, Yang Z, He D, Yang L, Liu Z, et al. 2022. A multi-omics study of familial lung cancer: microbiome and host gene expression patterns. Front Immunol. 13:827953. doi:10.3389/fimmu.2022.827953.
  • Cheng X, Huang F, Zhang K, Yuan X, Song C. 2018. Effects of none-steroidal anti-inflammatory and antibiotic drugs on the oral immune system and oral microbial composition in rats. Biochem Biophys Res Commun. 507(1–4):420–425. doi:10.1016/j.bbrc.2018.11.054.
  • Choi H, Park HY, Han K, Yoo J, Shin SH, Yang B, Kim Y, Park TS, Park DW, Moon JY, et al. 2022. Non-cystic fibrosis bronchiectasis increases the risk of lung cancer independent of smoking status. Ann Am Thorac Soc. 19(9):1551–1560. doi:10.1513/AnnalsATS.202111-1257OC.
  • Chrysanthakopoulos NA. 2016. Correlation between periodontal disease indices and lung cancer in Greek adults: a case-control study. Exp Onc. 38(1):49–53. doi:10.31768/2312-8852.2016.38(1):49-53.
  • Chu S, Cheng Z, Yin Z, Xu J, Wu F, Jin Y, Yang G. 2022. Airway fusobacterium is associated with poor response to immunotherapy in lung cancer. Onco Targets Ther. 15:201–213. doi:10.2147/OTT.S348382.
  • Cutler CW, Kalmar JR, Genco CA. 1995. Pathogenic strategies of the oral anaerobe, Porphyromonas gingivalis. Trends Microbiol. 3(2):45–51. doi:10.1016/s0966-842x(00)88874-5.
  • Dong J, Li W, Wang Q, Chen J, Zu Y, Zhou X, Guo Q. 2021. Relationships between oral microecosystem and respiratory diseases. Front Mol Biosci. 8:718222. doi:10.3389/fmolb.2021.718222.
  • Dong Q, Chen ES, Zhao C, Jin C. 2021. Host-microbiome interaction in lung cancer. Front Immunol. 12:679829. doi:10.3389/fimmu.2021.679829.
  • Durack J, Christian LS, Nariya S, Gonzalez J, Bhakta NR, Ansel KM, Beigelman A, Castro M, Dyer AM, Israel E, et al. 2020. Distinct associations of sputum and oral microbiota with atopic, immunologic, and clinical features in mild asthma. J Allergy Clin Immunol. 146(5):1016–1026. doi:10.1016/j.jaci.2020.03.028.
  • Filippini T, Malavolti M, Borrelli F, Izzo AA, Fairweather-Tait SJ, Horneber M, Vinceti M. 2020. Green tea (Camellia sinensis) for the prevention of cancer. Cochrane Database Syst Rev. 3(3):Cd005004. doi:10.1002/14651858.CD005004.pub3.
  • Fink DL, Green BA, St Geme JW, 3rd. 2002. The Haemophilus influenzae Hap autotransporter binds to fibronectin, laminin, and collagen IV. Infect Immun. 70(9):4902–4907. doi:10.1128/IAI.70.9.4902-4907.2002.
  • Frey DL, Boutin S, Dittrich SA, Graeber SY, Stahl M, Wege S, Herth FJF, Sommerburg O, Schultz C, Mall MA, et al. 2021. Relationship between airway dysbiosis, inflammation and lung function in adults with cystic fibrosis. J Cyst Fibros. 20(5):754–760. doi:10.1016/j.jcf.2020.12.022.
  • Gaeckle NT, Pragman AA, Pendleton KM, Baldomero AK, Criner GJ. 2020. The oral-lung axis: the impact of oral health on lung health. Respir Care. 65(8):1211–1220. doi:10.4187/respcare.07332.
  • Gao L, Xu T, Huang G, Jiang S, Gu Y, Chen F. 2018. Oral microbiomes: more and more importance in oral cavity and whole body. Protein Cell. 9(5):488–500. doi:10.1007/s13238-018-0548-1.
  • Gheisary Z, Mahmood R, Harri Shivanantham A, Liu J, Lieffers JRL, Papagerakis P, Papagerakis S. 2022. The clinical, microbiological, and immunological effects of probiotic supplementation on prevention and treatment of periodontal diseases: a systematic review and meta-analysis. Nutrients. 14(5):1036. doi:10.3390/nu14051036.
  • Goeminne PC, Nawrot TS, Ruttens D, Seys S, Dupont LJ. 2014. Mortality in non-cystic fibrosis bronchiectasis: a prospective cohort analysis. Respir Med. 108(2):287–296. doi:10.1016/j.rmed.2013.12.015.
  • Greathouse KL, White JR, Vargas AJ, Bliskovsky VV, Beck JA, von Muhlinen N, Polley EC, Bowman ED, Khan MA, Robles AI, et al. 2018. Interaction between the microbiome and TP53 in human lung cancer. Genome Biol. 19(1):123. doi:10.1186/s13059-018-1501-6.
  • Groeger S, Meyle J. 2019. Oral mucosal epithelial cells. Front Immunol. 10:208. doi:10.3389/fimmu.2019.00208.
  • Gu JY, Liu YJ, Zhu XQ, Qiu JY, Sun Y. 2020. Effects of endotoxin tolerance induced by Porphyromonas gingivalis lipopolysaccharide on inflammatory responses in neutrophils. Inflammation. 43(5):1692–1706. doi:10.1007/s10753-020-01243-8.
  • Hakozaki T, Richard C, Elkrief A, Hosomi Y, Benlaïfaoui M, Mimpen I, Terrisse S, Derosa L, Zitvogel L, Routy B, et al. 2020. The gut microbiome associates with immune checkpoint inhibition outcomes in patients with advanced non-small cell lung cancer. Cancer Immunol Res. 8(10):1243–1250. doi:10.1158/2326-6066.CIR-20-0196.
  • Hansen TH, Kern T, Bak EG, Kashani A, Allin KH, Nielsen T, Hansen T, Pedersen O. 2018. Impact of a vegan diet on the human salivary microbiota. Sci Rep. 8(1):5847. doi:10.1038/s41598-018-24207-3.
  • Hayata M, Watanabe N, Tamura M, Kamio N, Tanaka H, Nodomi K, Miya C, Nakayama E, Ueda K, Ogata Y, et al. 2019. The periodontopathic bacterium Fusobacterium nucleatum induced proinflammatory cytokine production by human respiratory epithelial cell lines and in the lower respiratory organs in mice. Cell Physiol Biochem. 53:49–61.
  • Heinrich J, Thiering E, Jörres RA, Schulz H, Kühnisch J, Standl M. 2019. Lung function and oral health in adolescents. Eur Respir J. 53(3):1801951. doi:10.1183/13993003.01951-2018.
  • Hentilä J, Laakamaa N, Sorsa T, Meurman J, Välimaa H, Nikinmaa S, Kankuri E, Tauriainen T, Pätilä T. 2021. Dual-light photodynamic therapy effectively eliminates Streptococcus oralis biofilms. J Pharm Pharm Sci. 24:484–487. doi:10.18433/jpps32084.
  • Herbert BA, Novince CM, Kirkwood KL. 2016. Aggregatibacter actinomycetemcomitans, a potent immunoregulator of the periodontal host defense system and alveolar bone homeostasis. Mol Oral Microbiol. 31(3):207–227. doi:10.1111/omi.12119.
  • Hirsch FR, Scagliotti GV, Mulshine JL, Kwon R, Curran WJ, Jr, Wu YL, Paz-Ares L. 2017. Lung cancer: current therapies and new targeted treatments. Lancet. 389(10066):299–311. doi:10.1016/S0140-6736(16)30958-8.
  • Hosgood HD, Cai Q, Hua X, Long J, Shi J, Wan Y, Yang Y, Abnet C, Bassig BA, Hu W, et al. 2021. Variation in oral microbiome is associated with future risk of lung cancer among never-smokers. Thorax. 76(3):256–263. doi:10.1136/thoraxjnl-2020-215542.
  • Huang KY, Chang TH, Jhong JH, Chi YH, Li WC, Chan CL, Robert Lai K, Lee TY. 2017. Identification of natural antimicrobial peptides from bacteria through metagenomic and metatranscriptomic analysis of high-throughput transcriptome data of Taiwanese oolong teas. BMC Syst Biol. 11(Suppl 7):131. doi:10.1186/s12918-017-0503-4.
  • Hujoel PP, Drangsholt M, Spiekerman C, Weiss NS. 2003. An exploration of the periodontitis-cancer association. Ann Epidemiol. 13(5):312–316. doi:10.1016/s1047-2797(02)00425-8.
  • Inomata M, Xu S, Chandra P, Meydani SN, Takemura G, Philips JA, Leong JM. 2020. Macrophage LC3-associated phagocytosis is an immune defense against Streptococcus pneumoniae that diminishes with host aging. Proc Natl Acad Sci U S A. 117(52):33561–33569. doi:10.1073/pnas.2015368117.
  • Iwata E, Hasegawa T, Yamada SI, Kawashita Y, Yoshimatsu M, Mizutani T, Nakahara H, Mori K, Shibuya Y, Kurita H, et al. 2019. Effects of perioperative oral care on prevention of postoperative pneumonia after lung resection: Multicenter retrospective study with propensity score matching analysis. Surgery. 165(5):1003–1007. doi:10.1016/j.surg.2018.11.020.
  • Jeon KH, Shin DW, Han K, Kim D, Yoo JE, Jeong SM, Cho JH. 2020. Female reproductive factors and the risk of lung cancer in postmenopausal women: a nationwide cohort study. Br J Cancer. 122(9):1417–1424. doi:10.1038/s41416-020-0789-7.
  • Jiang L, Sun YQ, Langhammer A, Brumpton BM, Chen Y, Nilsen TI, Leivseth L, Wahl SGF, Mai XM. 2021. Asthma and asthma symptom control in relation to incidence of lung cancer in the HUNT study. Sci Rep. 11(1):4539. doi:10.1038/s41598-021-84012-3.
  • Jiang X, Liu S, Zhang Y, Ji Y, Sohail A, Cao C, Wang P, Xiao H. 2020. Free-FLOW ISOELECTRIC FOCUSING FOR COMPREHENSIVE SEPARATION AND ANALYSIS OF HUMAN SALIVARY MICROBIOME FOR LUNG CANCER. Anal Chem. 92(17):12017–12025. doi:10.1021/acs.analchem.0c02627.
  • Jin C, Lagoudas GK, Zhao C, Bullman S, Bhutkar A, Hu B, Ameh S, Sandel D, Liang XS, Mazzilli S, et al. 2019. Commensal microbiota promote lung cancer development via γδ T cells. Cell. 176(5):998–1013.e16. doi:10.1016/j.cell.2018.12.040.
  • Johannesen KM, Kolekar SB, Greve N, Nielsen XC, Barfod TS, Bodtger U. 2019. Differences in mortality in Fusobacterium necrophorum and Fusobacterium nucleatum infections detected by culture and 16S rRNA gene sequencing. Eur J Clin Microbiol Infect Dis. 38(1):75–80. doi:10.1007/s10096-018-3394-4.
  • Jungnickel C, Schnabel PA, Bohle R, Wiewrodt R, Herr C, Bals R, Beisswenger C. 2017. Nontypeable Haemophilus influenzae-promoted proliferation of Kras-induced early adenomatous lesions is completely dependent on toll-like receptor signaling. Am J Pathol. 187(5):973–979. doi:10.1016/j.ajpath.2017.01.003.
  • Jungnickel C, Wonnenberg B, Karabiber O, Wolf A, Voss M, Wolf L, Honecker A, Kamyschnikow A, Herr C, Bals R, et al. 2015. Cigarette smoke-induced disruption of pulmonary barrier and bacterial translocation drive tumor-associated inflammation and growth. Am J Physiol Lung Cell Mol Physiol. 309(6):L605–613. doi:10.1152/ajplung.00116.2015.
  • Kane-Diallo A, Srour B, Sellem L, Deschasaux M, Latino-Martel P, Hercberg S, Galan P, Fassier P, Guéraud F, Pierre FH, et al. 2018. Association between a pro plant-based dietary score and cancer risk in the prospective NutriNet-santé cohort. Int J Cancer. 143(9):2168–2176. doi:10.1002/ijc.31593.
  • Karpiński TM. 2019. Role of oral microbiota in cancer development. Microorganisms. 7(1):20. doi:10.3390/microorganisms7010020.
  • Kato S, Saito A, Matsuda N, Suzuki H, Ujiie M, Sato S, Miyazaki K, Kodama T, Satoh H. 2017. Management of afatinib-induced stomatitis. Mol Clin Oncol. 6(4):603–605. doi:10.3892/mco.2017.1184.
  • Khurana R, Kakatkar AS, Chatterjee S, Barooah N, Kunwar A, Bhasikuttan AC, Mohanty J. 2019. Supramolecular nanorods of (N-Methylpyridyl) porphyrin with captisol: effective photosensitizer for anti-bacterial and anti-tumor activities. Front Chem. 7:452. doi:10.3389/fchem.2019.00452.
  • Kim Y, Han K, Yoo J, Kang HK, Park TS, Park DW, Hong JY, Moon JY, Kim SH, Kim TH, et al. 2022. Risk factors of incident lung cancer in patients with non-cystic fibrosis bronchiectasis: a Korean population-based study. Cancers (Basel). 14(11):2604. doi:10.3390/cancers14112604.
  • Kjaer SK, Dehlendorff C, Belmonte F, Baandrup L. 2021. Real-world effectiveness of human papillomavirus vaccination against cervical cancer. J Natl Cancer Inst. 113(10):1329–1335. doi:10.1093/jnci/djab080.
  • Koeman M, van der Ven AJ, Hak E, Joore HC, Kaasjager K, de Smet AG, Ramsay G, Dormans TP, Aarts LP, de Bel EE, et al. 2006. Oral decontamination with chlorhexidine reduces the incidence of ventilator-associated pneumonia. Am J Respir Crit Care Med. 173(12):1348–1355. doi:10.1164/rccm.200505-820OC.
  • Kosikowska U, Biernasiuk A, Rybojad P, Łoś R, Malm A. 2016. Haemophilus parainfluenzae as a marker of the upper respiratory tract microbiota changes under the influence of preoperative prophylaxis with or without postoperative treatment in patients with lung cancer. BMC Microbiol. 16(1):62. doi:10.1186/s12866-016-0679-6.
  • Kostic AD, Chun E, Robertson L, Glickman JN, Gallini CA, Michaud M, Clancy TE, Chung DC, Lochhead P, Hold GL, et al. 2013. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe. 14(2):207–215. doi:10.1016/j.chom.2013.07.007.
  • Kwiatkowski S, Knap B, Przystupski D, Saczko J, Kędzierska E, Knap-Czop K, Kotlińska J, Michel O, Kotowski K, Kulbacka J. 2018. Photodynamic therapy - mechanisms, photosensitizers and combinations. Biomed Pharmacother. 106:1098–1107. doi:10.1016/j.biopha.2018.07.049.
  • Lamont RJ, Koo H, Hajishengallis G. 2018. The oral microbiota: dynamic communities and host interactions. Nat Rev Microbiol. 16(12):745–759. doi:10.1038/s41579-018-0089-x.
  • LaPenta D, Rubens C, Chi E, Cleary PP. 1994. Group A streptococci efficiently invade human respiratory epithelial cells. Proc Natl Acad Sci U S A. 91(25):12115–12119. doi:10.1073/pnas.91.25.12115.
  • Larsson SC, Carter P, Kar S, Vithayathil M, Mason AM, Michaëlsson K, Burgess S. 2020. Smoking, alcohol consumption, and cancer: a mendelian randomisation study in UK Biobank and international genetic consortia participants. PLoS Med. 17(7):e1003178. doi:10.1371/journal.pmed.1003178.
  • Laupland KB, Paterson DL, Stewart AG, Edwards F, Harris PNA. 2022. Sphingomonas paucimobilis bloodstream infection is a predominantly community-onset disease with significant lethality. Int J Infect Dis. 119:172–177. doi:10.1016/j.ijid.2022.03.060.
  • Leng Q, Holden VK, Deepak J, Todd NW, Jiang F. 2021. Microbiota biomarkers for lung cancer. Diagnostics (Basel). 11(3):407. doi:10.3390/diagnostics11030407.
  • Li L, Zhang J, Li Z, Zhang C, Bi J, Zhou J, Song Y, Shao C. 2021. Airway microbiota is associated with the severity of non-CF bronchiectasis. Clin Respir J. 15(2):154–162. doi:10.1111/crj.13279.
  • Limsuwan S, Homlaead S, Watcharakul S, Chusri S, Moosigapong K, Saising J, Voravuthikunchai SP. 2014. Inhibition of microbial adhesion to plastic surface and human buccal epithelial cells by Rhodomyrtus tomentosa leaf extract. Arch Oral Biol. 59(12):1256–1265. doi:10.1016/j.archoralbio.2014.07.017.
  • Lin F, Luo X, Tsun A, Li Z, Li D, Li B. 2015. Kaempferol enhances the suppressive function of Treg cells by inhibiting FOXP3 phosphorylation. Int Immunopharmacol. 28(2):859–865. doi:10.1016/j.intimp.2015.03.044.
  • Liu C, Cao Y, Lin J, Ng L, Needleman I, Walsh T, Li C. 2018. Oral care measures for preventing nursing home-acquired pneumonia. Cochrane Database Syst Rev. 9:Cd012416.
  • Liu HX, Tao LL, Zhang J, Zhu YG, Zheng Y, Liu D, Zhou M, Ke H, Shi MM, Qu JM. 2018. Difference of lower airway microbiome in bilateral protected specimen brush between lung cancer patients with unilateral lobar masses and control subjects. Int J Cancer. 142(4):769–778. doi:10.1002/ijc.31098.
  • Liu M, Liu X, Suo P, Gong Y, Qu B, Peng X, Xiao W, Li Y, Chen Y, Zeng Z, et al. 2020. The contribution of hereditary cancer-related germline mutations to lung cancer susceptibility. Transl Lung Cancer Res. 9(3):646–658. doi:10.21037/tlcr-19-403.
  • Liu S, Fu Y, Ziebolz D, Li S, Schmalz G, Li F. 2022. Transcriptomic analysis reveals pathophysiological relationship between chronic obstructive pulmonary disease (COPD) and periodontitis. BMC Med Genomics. 15(1):130. doi:10.1186/s12920-022-01278-w.
  • Liu Y, Yuan X, Chen K, Zhou F, Yang H, Yang H, Qi Y, Kong J, Sun W, Gao S. 2021. Clinical significance and prognostic value of Porphyromonas gingivalis infection in lung cancer. Transl Oncol. 14(1):100972. doi:10.1016/j.tranon.2020.100972.
  • Liu Z, Guo H, Zhang W, Ni L. 2020. Salivary microbiota shifts under sustained consumption of oolong tea in healthy adults. Nutrients. 12(4):966. doi:10.3390/nu12040966.
  • Luo YX, Sun ML, Shi PL, Liu P, Chen YY[, Peng X. 2020. Research progress in the relationship between Veillonella and oral diseases. Hua Xi Kou Qiang Yi Xue Za Zhi. 38:576–582.
  • Machida H, Inoue S, Shibata Y, Kimura T, Ota T, Ishibashi Y, Murano H, Furuyama K, Yang S, Nakano H, et al. 2021. The incidence and risk analysis of lung cancer development in patients with chronic obstructive pulmonary disease: possible effectiveness of annual CT-screening. Int J Chron Obstruct Pulmon Dis. 16:739–749. doi:10.2147/COPD.S287492.
  • Malhotra J, Malvezzi M, Negri E, La Vecchia C, Boffetta P. 2016. Risk factors for lung cancer worldwide. Eur Respir J. 48(3):889–902. doi:10.1183/13993003.00359-2016.
  • Mammen MJ, Scannapieco FA, Sethi S. 2020. Oral-lung microbiome interactions in lung diseases. Periodontol 2000. 83(1):234–241. doi:10.1111/prd.12301.
  • Man WH, Clerc M, de Steenhuijsen Piters WAA, van Houten MA, Chu M, Kool J, Keijser BJF, Sanders EAM, Bogaert D. 2019. Loss of microbial topography between oral and nasopharyngeal microbiota and development of respiratory infections early in life. Am J Respir Crit Care Med. 200(6):760–770. doi:10.1164/rccm.201810-1993OC.
  • Matsuzaki T, Yokokura T. 1987. Inhibition of tumor metastasis of Lewis lung carcinoma in C57BL/6 mice by intrapleural administration of Lactobacillus casei. Cancer Immunol Immunother. 25(2):100–104. doi:10.1007/BF00199948.
  • Memmert S, Gölz L, Pütz P, Jäger A, Deschner J, Appel T, Baumgarten G, Rath-Deschner B, Frede S, Götz W. 2016. Regulation of p53 under hypoxic and inflammatory conditions in periodontium. Clin Oral Investig. 20(7):1781–1789. doi:10.1007/s00784-015-1679-x.
  • Meng Q, Gao Q, Mehrazarin S, Tangwanichgapong K, Wang Y, Huang Y, Pan Y, Robinson S, Liu Z, Zangiabadi A, et al. 2021. Fusobacterium nucleatum secretes amyloid-like FadA to enhance pathogenicity. EMBO Rep. 22:e52891.
  • Meyer EH, Goya S, Akbari O, Berry GJ, Savage PB, Kronenberg M, Nakayama T, DeKruyff RH, Umetsu DT. 2006. Glycolipid activation of invariant T cell receptor + NK T cells is sufficient to induce airway hyperreactivity independent of conventional CD4+ T cells. Proc Natl Acad Sci U S A. 103(8):2782–2787. doi:10.1073/pnas.0510282103.
  • Mitsuwan W, Wintachai P, Voravuthikunchai SP. 2020. Rhodomyrtus tomentosa Leaf extract and rhodomyrtone combat Streptococcus pneumoniae biofilm and inhibit invasiveness to human lung epithelial and enhance pneumococcal phagocytosis by macrophage. Curr Microbiol. 77(11):3546–3554. doi:10.1007/s00284-020-02164-3.
  • Mobbs KJ, van Saene HK, Sunderland D, Davies PD. 1999. Oropharyngeal gram-negative bacillary carriage in chronic obstructive pulmonary disease: relation to severity of disease. Respir Med. 93(8):540–545. doi:10.1016/s0954-6111(99)90152-x.
  • Moghaddam A, Ranjbar R, Yazdanian M, Tahmasebi E, Alam M, Abbasi K, Hosseini ZS, Tebyaniyan H. 2022. The current antimicrobial and antibiofilm activities of synthetic/herbal/biomaterials in dental application. Biomed Res Int. 2022:8856025–8856026. doi:10.1155/2022/8856025.
  • Moghaddam SJ, Li H, Cho SN, Dishop MK, Wistuba II, Ji L, Kurie JM, Dickey BF, Demayo FJ. 2009. Promotion of lung carcinogenesis by chronic obstructive pulmonary disease-like airway inflammation in a K-ras-induced mouse model. Am J Respir Cell Mol Biol. 40(4):443–453. doi:10.1165/rcmb.2008-0198OC.
  • Morrison L, Zembower TR. 2020. Antimicrobial resistance. Gastrointest Endosc Clin N Am. 30(4):619–635. doi:10.1016/j.giec.2020.06.004.
  • Nascimento MM. 2017. Oral microbiota transplant: a potential new therapy for oral diseases. J Calif Dent Assoc. 45(10):565–568. doi:10.1080/19424396.2017.12222506.
  • Nath S, Zilm P, Jamieson L, Kapellas K, Goswami N, Ketagoda K, Weyrich LS. 2021. Development and characterization of an oral microbiome transplant among Australians for the treatment of dental caries and periodontal disease: a study protocol. PLoS One. 16(11):e0260433. doi:10.1371/journal.pone.0260433.
  • National Lung Screening Trial Research Team. 2019. Lung cancer incidence and mortality with extended follow-up in the national lung screening trial. J Thorac Oncol. 14:1732–1742.
  • Nishizawa T, Niikura Y, Akasaka K, Watanabe M, Kurai D, Amano M, Ishii H, Matsushima H, Yamashita N, Takizawa H. 2019. Pilot study for risk assessment of aspiration pneumonia based on oral bacteria levels and serum biomarkers. BMC Infect Dis. 19(1):761. doi:10.1186/s12879-019-4327-2.
  • Nunpan S, Suwannachart C, Wayakanon K. 2019. Effect of prebiotics-enhanced probiotics on the growth of Streptococcus mutans. Int J Microbiol. 2019:4623807–4623807. doi:10.1155/2019/4623807.
  • Olsen I, Taubman MA, Singhrao SK. 2016. Porphyromonas gingivalis suppresses adaptive immunity in periodontitis, atherosclerosis, and Alzheimer’s disease. J Oral Microbiol. 8(1):33029. doi:10.3402/jom.v8.33029.
  • Ortega E, Pérez-Arnaiz C, Rodríguez V, Janiak C, Busto N, García B, Ruiz J. 2021. A 2-(benzothiazol-2-yl)-phenolato platinum(II) complex as potential photosensitizer for combating bacterial infections in lung cancer chemotherapy†. Eur J Med Chem. 222:113600. doi:10.1016/j.ejmech.2021.113600.
  • Parhi L, Alon-Maimon T, Sol A, Nejman D, Shhadeh A, Fainsod-Levi T, Yajuk O, Isaacson B, Abed J, Maalouf N, et al. 2020. Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression. Nat Commun. 11(1):3259. doi:10.1038/s41467-020-16967-2.
  • Park OJ, Cho MK, Yun CH, Han SH. 2015. Lipopolysaccharide of Aggregatibacter actinomycetemcomitans induces the expression of chemokines MCP-1, MIP-1α, and IP-10 via similar but distinct signaling pathways in murine macrophages. Immunobiology. 220(9):1067–1074. doi:10.1016/j.imbio.2015.05.008.
  • Passarelli Mantovani R, Sandri A, Boaretti M, Grilli A, Volpi S, Melotti P, Burlacchini G, Lleò MM, Signoretto C. 2019. Toothbrushes may convey bacteria to the cystic fibrosis lower airways. J Oral Microbiol. 11(1):1647036. doi:10.1080/20002297.2019.1647036.
  • Pathak JL, Yan Y, Zhang Q, Wang L, Ge L. 2021. The role of oral microbiome in respiratory health and diseases. Respir Med. 185:106475. doi:10.1016/j.rmed.2021.106475.
  • Patnaik SK, Cortes EG, Kannisto ED, Punnanitinont A, Dhillon SS, Liu S, Yendamuri S. 2021. Lower airway bacterial microbiome may influence recurrence after resection of early-stage non-small cell lung cancer. J Thorac Cardiovasc Surg. 161(2):419–429.e16. e416. doi:10.1016/j.jtcvs.2020.01.104.
  • Pawlaczyk-Kamieńska T, Borysewicz-Lewicka M, Śniatała R, Batura-Gabryel H, Cofta S. 2019. Dental and periodontal manifestations in patients with cystic fibrosis - a systematic review. J Cyst Fibros. 18(6):762–771. doi:10.1016/j.jcf.2018.11.007.
  • Pinto EH, Longo PL, de Camargo CCB, Dal Corso S, Lanza FDC, Stelmach R, Athanazio R, Fernandes KPS, Mayer MPA, Bussadori SK, et al. 2016. Assessment of the quantity of microorganisms associated with bronchiectasis in saliva, sputum and nasal lavage after periodontal treatment: a study protocol of a randomised controlled trial. BMJ Open. 6(4):e010564. doi:10.1136/bmjopen-2015-010564.
  • Pizzo F, Maroccia Z, Hammarberg Ferri I, Fiorentini C. 2022. Role of the microbiota in lung cancer: insights on prevention and treatment. Int J Mol Sci. 23(11):6138. doi:10.3390/ijms23116138.
  • Pozhitkov AE, Leroux BG, Randolph TW, Beikler T, Flemmig TF, Noble PA. 2015. Towards microbiome transplant as a therapy for periodontitis: an exploratory study of periodontitis microbial signature contrasted by oral health, caries and edentulism. BMC Oral Health. 15(1):125. doi:10.1186/s12903-015-0109-4.
  • Pulito C, Cristaudo A, Porta C, Zapperi S, Blandino G, Morrone A, Strano S. 2020. Oral mucositis: the hidden side of cancer therapy. J Exp Clin Cancer Res. 39(1):210. doi:10.1186/s13046-020-01715-7.
  • Qi M, Chi M, Sun X, Xie X, Weir MD, Oates TW, Zhou Y, Wang L, Bai Y, Xu HH. 2019. Novel nanomaterial-based antibacterial photodynamic therapies to combat oral bacterial biofilms and infectious diseases. Int J Nanomed. 14:6937–6956. doi:10.2147/IJN.S212807.
  • Rahman Fink N, Chawes BL, Thorsen J, Stokholm J, Krogfelt KA, Schjørring S, Kragh M, Bønnelykke K, Brix S, Bisgaard H. 2018. Neonates colonized with pathogenic bacteria in the airways have a low-grade systemic inflammation. Allergy. 73(11):2150–2159. doi:10.1111/all.13461.
  • Rai AK, Panda M, Das AK, Rahman T, Das R, Das K, Sarma A, Kataki AC, Chattopadhyay I. 2021. Dysbiosis of salivary microbiome and cytokines influence oral squamous cell carcinoma through inflammation. Arch Microbiol. 203(1):137–152. doi:10.1007/s00203-020-02011-w.
  • Ran Z, Liu J, Wang F, Xin C, Xiong B, Song Z. 2020. Pulmonary micro-ecological changes and potential microbial markers in lung cancer patients. Front Oncol. 10:576855. doi:10.3389/fonc.2020.576855.
  • Rao B, Lou J, Lu H, Liang H, Li J, Zhou H, Fan Y, Zhang H, Sun Y, Zou Y, et al. 2021. Oral microbiome characteristics in patients with autoimmune hepatitis. Front Cell Infect Microbiol. 11:656674. doi:10.3389/fcimb.2021.656674.
  • Rezaei MK, Nolan NJ, Schwartz AM. 2013. Surgical pathology of lung cancer. Semin Respir Crit Care Med. 34(6):770–786. doi:10.1055/s-0033-1358558.
  • Ringelhan M, McKeating JA, Protzer U. 2017. Viral hepatitis and liver cancer. Philos Trans R Soc Lond B Biol Sci. 372:1732. doi:10.1098/rstb.2016.0274.
  • Rivas Caldas R, Le Gall F, Revert K, Rault G, Virmaux M, Gouriou S, Héry-Arnaud G, Barbier G, Boisramé S. 2015. Pseudomonas aeruginosa and periodontal pathogens in the oral cavity and lungs of cystic fibrosis patients: a case-control study. J Clin Microbiol. 53(6):1898–1907. doi:10.1128/JCM.00368-15.
  • Rosa EP, Murakami-Malaquias-da-Silva F, Palma-Cruz M, de Carvalho Garcia G, Brito AA, Andreo L, Kamei SK, Negreiros RM, Rodrigues M, Mesquita-Ferrari RA, et al. 2020. The impact of periodontitis in the course of chronic obstructive pulmonary disease: pulmonary and systemic effects. Life Sci. 261:118257. doi:10.1016/j.lfs.2020.118257.
  • Roy P, Sarma A, Kataki AC, Rai AK. 2022. Chattopadhyay I: salivary microbial dysbiosis may predict lung adenocarcinoma: a pilot study. Indian J Pathol Microbiol. 65:123–128.
  • Salameh L, Mahboub B, Khamis A, Alsharhan M, Tirmazy SH, Dairi Y, Hamid Q, Hamoudi R, Al Heialy S. 2021. Asthma severity as a contributing factor to cancer incidence: a cohort study. PLoS One. 16(5):e0250430. doi:10.1371/journal.pone.0250430.
  • Sang-Ngoen T, Czumbel LM, Sadaeng W, Mikó A, Németh DI, Mátrai P, Hegyi P, Tóth B, Csupor D, Kiss I, et al. 2021. Orally administered probiotics decrease Aggregatibacter actinomycetemcomitans but not other periodontal pathogenic bacteria counts in the oral cavity: a systematic review and meta-analysis. Front Pharmacol. 12:682656. doi:10.3389/fphar.2021.682656.
  • Sato T, Tomida J, Naka T, Fujiwara N, Hasegawa A, Hoshikawa Y, Matsuyama J, Ishida N, Kondo T, Tanaka K, et al. 2015. Porphyromonas bronchialis sp. nov. isolated from intraoperative bronchial fluids of a patient with non-small cell lung cancer. Tohoku J Exp Med. 237(1):31–37. doi:10.1620/tjem.237.31.
  • Scannapieco FA. 2021. Poor oral health in the etiology and prevention of aspiration pneumonia. Dent Clin North Am. 65(2):307–321. doi:10.1016/j.cden.2020.11.006.
  • Schmidlin PR, Fachinger P, Tini G, Graber S, Seifert B, Dombrowa S, Irani S. 2015. Shared microbiome in gums and the lung in an outpatient population. J Infect. 70(3):255–263. doi:10.1016/j.jinf.2014.10.005.
  • Sedghi LM, Green SJ, Byron CD. 2021. Measuring effects of dietary fiber on the murine oral microbiome with enrichment of 16S rDNA prior to amplicon synthesis. Methods Mol Biol. 2327:271–280. doi:10.1007/978-1-0716-1518-8_16.
  • Segal LN, Clemente JC, Tsay JC, Koralov SB, Keller BC, Wu BG, Li Y, Shen N, Ghedin E, Morris A, et al. 2016. Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype. Nat Microbiol. 1(5):16031. doi:10.1038/nmicrobiol.2016.31.
  • Shen TC, Chang PY, Lin CL, Wei CC, Tu CY, Hsia TC, Shih CM, Hsu WH, Sung FC, Kao CH. 2017. Impact of periodontal treatment on hospitalization for adverse respiratory events in asthmatic adults: a propensity-matched cohort study. Eur J Intern Med. 46:56–60. doi:10.1016/j.ejim.2017.06.005.
  • Shi J, Yang Y, Xie H, Wang X, Wu J, Long J, Courtney R, Shu XO, Zheng W, Blot WJ, et al. 2021. Association of oral microbiota with lung cancer risk in a low-income population in the Southeastern USA. Cancer Causes Control. 32(12):1423–1432. doi:10.1007/s10552-021-01490-6.
  • Shin DU, Eom JE, Song HJ, Jung SY, Nguyen TV, Lim KM, Chai OH, Kim HJ, Kim GD, Shin HS, et al. 2022. Camellia sinensis L. Alleviates pulmonary inflammation induced by porcine pancreas elastase and cigarette smoke extract. Antioxidants (Basel). 11(9):1683. doi:10.3390/antiox11091683.
  • Shivaji K, Mani S, Ponmurugan P, De Castro CS, Lloyd Davies M, Balasubramanian MG, Pitchaimuthu S. 2018. Green-synthesis-derived CdS quantum dots using tea leaf extract: antimicrobial, bioimaging, and therapeutic applications in lung cancer cells. ACS Appl Nano Mater. 1(4):1683–1693. doi:10.1021/acsanm.8b00147.
  • Short B, Carson S, Devlin AC, Reihill JA, Crilly A, MacKay W, Ramage G, Williams C, Lundy FT, McGarvey LP, et al. 2021. Non-typeable Haemophilus influenzae chronic colonization in chronic obstructive pulmonary disease (COPD). Crit Rev Microbiol. 47(2):192–205. doi:10.1080/1040841X.2020.1863330.
  • Sin S, Yun SY, Kim JM, Park CM, Cho J, Choi SM, Lee J, Park YS, Lee SM, Yoo CG, et al. 2019. Mortality risk and causes of death in patients with non-cystic fibrosis bronchiectasis. Respir Res. 20(1):271. doi:10.1186/s12931-019-1243-3.
  • Skolnik K, Nguyen A, Somayaji R, Thornton CS, Waddell B, Surette MG, Rabin HR, Parkins MD. 2015. Clinical implications and characterization of Group A Streptoccoccus infections in adults with cystic fibrosis. BMC Pulm Med. 15(1):161. doi:10.1186/s12890-015-0157-1.
  • Skoulidis F, Byers LA, Diao L, Papadimitrakopoulou VA, Tong P, Izzo J, Behrens C, Kadara H, Parra ER, Canales JR, et al. 2015. Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities. Cancer Discov. 5(8):860–877. doi:10.1158/2159-8290.CD-14-1236.
  • Smith MP. 2011. Non-cystic fibrosis bronchiectasis. J R Coll Physicians Edinb. 41(2):132–139; quiz 139. doi:10.4997/JRCPE.2011.217.
  • Socransky SS, Haffajee AD. 1992. The bacterial etiology of destructive periodontal disease: current concepts. J Periodontol. 63 Suppl 4S(4s):322–331. doi:10.1902/jop.1992.63.4s.322.
  • Söder B, Källmén H, Yucel-Lindberg T, Meurman JH. 2021. Periodontal microorganisms and diagnosis of malignancy: a cross-sectional study. Tumour Biol. 43(1):1–9. doi:10.3233/TUB-200066.
  • Son M, Jo S, Lee JS, Lee DH. 2020. Association between oral health and incidence of pneumonia: a population-based cohort study from Korea. Sci Rep. 10(1):9576. doi:10.1038/s41598-020-66312-2.
  • Son YO, Jeon YM, Kim YS, Park SS, Park SM, Kim JH, Lee JC. 2012. Streptococcus mutans GS-5 antigen I/II stimulates cell survival in serum deprived-cultures through PI3K/Akt pathways. J Cell Biochem. 113(5):1724–1732. doi:10.1002/jcb.24042.
  • Sundh J, Tanash H, Arian R, Neves-Guimaraes A, Broberg K, Lindved G, Kern T, Zych K, Nielsen HB, Halling A, et al. 2021. Advanced dental cleaning is associated with reduced risk of COPD exacerbations - a randomized controlled trial. Int J Chron Obstruct Pulmon Dis. 16:3203–3215. doi:10.2147/COPD.S327036.
  • Suprewicz Ł, Tokajuk G, Cieśluk M, Deptuła P, Sierpińska T, Wolak P, Wollny T, Tokajuk J, Głuszek S, Piktel E, et al. 2020. Bacteria residing at root canals can induce cell proliferation and alter the mechanical properties of gingival and cancer cells. Int J Mol Sci. 21(21):7914. doi:10.3390/ijms21217914.
  • Takahashi N. 2015. Oral microbiome metabolism: from “who are they?” to “what are they doing?”. J Dent Res. 94(12):1628–1637. doi:10.1177/0022034515606045.
  • Teles FRF, Alawi F, Castilho RM, Wang Y. 2020. Association or causation? Exploring the oral microbiome and cancer links. J Dent Res. 99(13):1411–1424. doi:10.1177/0022034520945242.
  • Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, et al. 2010. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 363(8):733–742. doi:10.1056/NEJMoa1000678.
  • Tomita Y, Goto Y, Sakata S, Imamura K, Minemura A, Oka K, Hayashi A, Jodai T, Akaike K, Anai M, et al. 2022. Clostridium butyricum therapy restores the decreased efficacy of immune checkpoint blockade in lung cancer patients receiving proton pump inhibitors. Oncoimmunology. 11(1):2081010. doi:10.1080/2162402X.2022.2081010.
  • Tsay JJ, Wu BG, Badri MH, Clemente JC, Shen N, Meyn P, Li Y, Yie TA, Lhakhang T, Olsen E, et al. 2018. Airway microbiota is associated with upregulation of the PI3K pathway in lung cancer. Am J Respir Crit Care Med. 198(9):1188–1198. doi:10.1164/rccm.201710-2118OC.
  • Tsay JJ, Wu BG, Sulaiman I, Gershner K, Schluger R, Li Y, Yie TA, Meyn P, Olsen E, Perez L, et al. 2021. Lower airway dysbiosis affects lung cancer progression. Cancer Discov. 11(2):293–307. doi:10.1158/2159-8290.CD-20-0263.
  • Turek EM, Cox MJ, Hunter M, Hui J, James P, Willis-Owen SAG, Cuthbertson L, James A, Musk AW, Moffatt MF, et al. 2021. Airway microbial communities, smoking and asthma in a general population sample. EBioMedicine. 71:103538. doi:10.1016/j.ebiom.2021.103538.
  • Utter DR, Borisy GG, Eren AM, Cavanaugh CM, Mark Welch JL. 2020. Metapangenomics of the oral microbiome provides insights into habitat adaptation and cultivar diversity. Genome Biol. 21(1):293. doi:10.1186/s13059-020-02200-2.
  • Vega BA, Belinka BA, Jr., Kachlany SC. 2019. Aggregatibacter actinomycetemcomitans Leukotoxin (LtxA; Leukothera(®)):mechanisms of action and therapeutic applications. Toxins (Basel). 11(9):489. doi:10.3390/toxins11090489.
  • Vekens K, Vincken S, Hanon S, Demuynck K, Stylemans D, Vanderhelst E. 2021. Lung cancer in a CF patient: combination of bad luck or is there more to say? Acta Clin Belg. 76(5):379–380. doi:10.1080/17843286.2020.1737780.
  • Vieira AR, Abar L, Vingeliene S, Chan DS, Aune D, Navarro-Rosenblatt D, Stevens C, Greenwood D, Norat T. 2016. Fruits, vegetables and lung cancer risk: a systematic review and meta-analysis. Ann Oncol. 27(1):81–96. doi:10.1093/annonc/mdv381.
  • Vogtmann E, Hua X, Yu G, Purandare V, Hullings AG, Shao D, Wan Y, Li S, Dagnall CL, Jones K, et al. 2022. The oral microbiome and lung cancer risk: an analysis of 3 prospective cohort studies. J Natl Cancer Inst. 114(11):1501–1510. doi:10.1093/jnci/djac149.
  • Wang J, Yang X, Zou X, Zhang Y, Wang J, Wang Y. 2020. Relationship between periodontal disease and lung cancer: a systematic review and meta-analysis. J Periodontal Res. 55(5):581–593. doi:10.1111/jre.12772.
  • Wang K, Huang Y, Zhang Z, Liao J, Ding Y, Fang X, Liu L, Luo J, Kong J. 2019. A preliminary study of microbiota diversity in saliva and bronchoalveolar lavage fluid from patients with primary bronchogenic carcinoma. Med Sci Monit. 25:2819–2834. doi:10.12659/MSM.915332.
  • Wang X, Ma K, Chi L, Cui J, Jin L, Hu JF, Li W. 2016. Combining telomerase reverse transcriptase genetic variant rs2736100 with epidemiologic factors in the prediction of lung cancer susceptibility. J Cancer. 7(7):846–853. doi:10.7150/jca.13437.
  • Wang Y, Li J, Zhang H, Zheng X, Wang J, Jia X, Peng X, Xie Q, Zou J, Zheng L, et al. 2021. Probiotic Streptococcus salivarius K12 alleviates radiation-induced oral mucositis in mice. Front Immunol. 12:684824. doi:10.3389/fimmu.2021.684824.
  • Wang Z, Zhou X, Zhang J, Zhang L, Song Y, Hu FB, Wang C. 2009. Periodontal health, oral health behaviours, and chronic obstructive pulmonary disease. J Clin Periodontol. 36(9):750–755. doi:10.1111/j.1600-051X.2009.01448.x.
  • Watanabe N, Yokoe S, Ogata Y, Sato S, Imai K. 2020. Exposure to Porphyromonas gingivalis induces production of proinflammatory cytokine via TLR2 from human respiratory epithelial cells. J Clin Med. 9(11):3433. doi:10.3390/jcm9113433.
  • Watari J, Chen N, Amenta PS, Fukui H, Oshima T, Tomita T, Miwa H, Lim KJ, Das KM. 2014. Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development. World J Gastroenterol. 20(18):5461–5473. doi:10.3748/wjg.v20.i18.5461.
  • Webb K, Zain NMM, Stewart I, Fogarty A, Nash EF, Whitehouse JL, Smyth AR, Lilley AK, Knox A, Williams P, et al. 2022. Porphyromonas pasteri and Prevotella nanceiensis in the sputum microbiota are associated with increased decline in lung function in individuals with cystic fibrosis. J Med Microbiol. 71(2):71.
  • Wen S, Zhang Z, Ouyang Y, Liu J, Liang Z, Pi Y, Su Z, Chen D, Guo L, Jiang Q, et al. 2022. The role of oral microbiota in chronic obstructive pulmonary disease. Respiration. 101(9):859–868. doi:10.1159/000525605.
  • Xiao H, Fan Y, Li Y, Dong J, Zhang S, Wang B, Liu J, Liu X, Fan S, Guan J, et al. 2021. Oral microbiota transplantation fights against head and neck radiotherapy-induced oral mucositis in mice. Comput Struct Biotechnol J. 19:5898–5910. doi:10.1016/j.csbj.2021.10.028.
  • Xu H, Jenkinson HF, Dongari-Bagtzoglou A. 2014. Innocent until proven guilty: mechanisms and roles of Streptococcus-Candida interactions in oral health and disease. Mol Oral Microbiol. 29(3):99–116. doi:10.1111/omi.12049.
  • Yan X, Yang M, Liu J, Gao R, Hu J, Li J, Zhang L, Shi Y, Guo H, Cheng J, et al. 2015. Discovery and validation of potential bacterial biomarkers for lung cancer. Am J Cancer Res. 5:3111–3122.
  • Yang J, Mu X, Wang Y, Zhu D, Zhang J, Liang C, Chen B, Wang J, Zhao C, Zuo Z, et al. 2018. Dysbiosis of the salivary microbiome is associated with non-smoking female lung cancer and correlated with immunocytochemistry markers. Front Oncol. 8:520. doi:10.3389/fonc.2018.00520.
  • Yang JJ, Yu D, Xiang YB, Blot W, White E, Robien K, Sinha R, Park Y, Takata Y, Lazovich D, et al. 2020. Association of dietary fiber and yogurt consumption with lung cancer risk: a pooled analysis. JAMA Oncol. 6(2):e194107. doi:10.1001/jamaoncol.2019.4107.
  • Yang L, Dunlap DG, Qin S, Fitch A, Li K, Koch CD, Nouraie M, DeSensi R, Ho KS, Martinson JJ, et al. 2020. Alterations in oral microbiota in HIV are related to decreased pulmonary function. Am J Respir Crit Care Med. 201(4):445–457. doi:10.1164/rccm.201905-1016OC.
  • Yoon HS, Shu XO, Gao YT, Yang G, Cai H, Shi J, Yang JJ, Rothman N, Lan Q, Zheng W, et al. 2022. Tooth loss and risk of lung cancer among urban chinese adults: a cohort study with meta-analysis. Cancers (Basel). 14(10):2428. doi:10.3390/cancers14102428.
  • Yoon HS, Wen W, Long J, Zheng W, Blot WJ, Cai Q. 2019. Association of oral health with lung cancer risk in a low-income population of African Americans and European Americans in the Southeastern United States. Lung Cancer. 127:90–95. doi:10.1016/j.lungcan.2018.11.028.
  • Yu G, Phillips S, Gail MH, Goedert JJ, Humphrys MS, Ravel J, Ren Y, Caporaso NE. 2017. The effect of cigarette smoking on the oral and nasal microbiota. Microbiome. 5(1):3. doi:10.1186/s40168-016-0226-6.
  • Yuan JM, Sun C, Butler LM. 2011. Tea and cancer prevention: epidemiological studies. Pharmacol Res. 64(2):123–135. doi:10.1016/j.phrs.2011.03.002.
  • Zaura E, Brandt BW, Teixeira de Mattos MJ, Buijs MJ, Caspers MP, Rashid MU, Weintraub A, Nord CE, Savell A, Hu Y, et al. 2015. Same exposure but two radically different responses to antibiotics: resilience of the salivary microbiome versus long-term microbial shifts in feces. mBio. 6(6):e01693-01615–e01615. doi:10.1128/mBio.01693-15.
  • Zaura E, Twetman S. 2019. Critical appraisal of oral pre- and probiotics for caries prevention and care. Caries Res. 53(5):514–526. doi:10.1159/000499037.
  • Zeng Y, Nikitkova A, Abdelsalam H, Li J, Xiao J. 2019. Activity of quercetin and kaemferol against Streptococcus mutans biofilm. Arch Oral Biol. 98:9–16. doi:10.1016/j.archoralbio.2018.11.005.
  • Zhang C, Wang J, Sun Z, Cao Y, Mu Z, Ji X. 2021. Commensal microbiota contributes to predicting the response to immune checkpoint inhibitors in non-small-cell lung cancer patients. Cancer Sci. 112(8):3005–3017. doi:10.1111/cas.14979.
  • Zhang J, Zhao T, Long S, Liu X, Yu H. 2017. Risk factors for postoperative infection in Chinese lung cancer patients: a meta-analysis. J Evid Based Med. 10(4):255–262. doi:10.1111/jebm.12276.
  • Zhang T, Kayani MUR, Hong L, Zhang C, Zhong J, Wang Z, Chen L. 2020. Dynamics of the salivary microbiome during different phases of Crohn’s disease. Front Cell Infect Microbiol. 10:544704. doi:10.3389/fcimb.2020.544704.
  • Zhang W, Luo J, Dong X, Zhao S, Hao Y, Peng C, Shi H, Zhou Y, Shan L, Sun Q, et al. 2019. Salivary microbial dysbiosis is associated with systemic inflammatory markers and predicted oral metabolites in non-small cell lung cancer patients. J Cancer. 10(7):1651–1662. doi:10.7150/jca.28077.
  • Zhang Y, Wang X, Li H, Ni C, Du Z, Yan F. 2018. Human oral microbiota and its modulation for oral health. Biomed Pharmacother. 99:883–893. doi:10.1016/j.biopha.2018.01.146.
  • Zheng Y, Fang Z, Xue Y, Zhang J, Zhu J, Gao R, Yao S, Ye Y, Wang S, Lin C, et al. 2020. Specific gut microbiome signature predicts the early-stage lung cancer. Gut Microbes. 11(4):1030–1042. doi:10.1080/19490976.2020.1737487.
  • Zhou B, Lu J, Beck JD, Moss KL, Prizment AE, Demmer RT, Porosnicu Rodriguez KA, Joshu CE, Michaud DS, Platz EA. 2023. Periodontal and other oral bacteria and risk of lung cancer in the Atherosclerosis Risk in Communities (ARIC) Study. Cancer Epidemiol Biomarkers Prev. 32(4):505–515.
  • Zhou F, Qiao M, Zhou C. 2021. The cutting-edge progress of immune-checkpoint blockade in lung cancer. Cell Mol Immunol. 18(2):279–293. doi:10.1038/s41423-020-00577-5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.